A Systemic Screening for TB Disease in High-risk Groups in Barcelona
SYS-TB-S
Implementing a Systemic Screening for TB Disease in High-risk Groups in Barcelona Area
SYS-TB-S
Implementing a Systemic Screening for TB Disease in High-risk Groups in Barcelona Area
Sponsor study identifier
observational
3,000
1 country
1
Study Start
July 22, 2022
Actual (reported)Primary Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The purpose of this screening study is to identify and screen vulnerable population in Barcelona for active pulmonary tuberculosis
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 22, 2022
Actual (reported)November 22, 2024
Actual (reported)November 26, 2024
Actual (reported)December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Number of individuals who screen positive for pulmonary TB symptoms
Number of individuals who screen positive for pulmonary TB symptoms (cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks)
1 day
Number of individuals who are diagnosed with pulmonary TB symptoms
Number of individuals who are diagnosed with pulmonary TB symptoms after referral to the hospital
1 month
Cost-effectiveness analysis
1 day
Time spent during screening
1 day
Individuals from vulnerable populations residing in the Barcelona metropolitan area who are at high risk of developing tuberculosis (i.e. war refugees, migrants, individuals living in socio-deprived neighborhoods)
Individuals will be screened for cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks
Chest X-ray will be performed to diagnose or exclude TB
Individuals from populations identified as high-risk for tuberculosis in the Barcelona metropolitan area
IGTP
Badalona, 08916, Spain
Cristina Vilaplana, MD, PhD
Fundació i Hospital Germans Trias i Pujol (IGTP-HUGTIP)
First Submitted
November 22, 2024
First Posted
November 26, 2024
Study Start
July 22, 2022
Actual (reported)Primary Completion
December 31, 2026
EstimatedTreating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
November 29, 2024
Record last verified: 2024-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: